Journal of Nippon Medical School
Online ISSN : 1347-3409
Print ISSN : 1345-4676
ISSN-L : 1345-4676
Pancreatic Ductal Adenocarcinoma Development in the Remnant Pancreas after Pancreaticoduodenectomy for Acinar Cell Carcinoma: A Case Report
Seitaro NishimuraMasashi UtsumiHideki AokiYuta UneHajime KashimaYuji KimuraFumitaka TaniguchiTakashi ArataKoh KatsudaKohji TanakayaYumiko Sato
Author information
JOURNALS FREE ACCESS Advance online publication

Article ID: JNMS.2018_86-501


We report the case of a pancreatic ductal adenocarcinoma (PDAC) in the remnant pancreas of a 78-year-old man after pancreaticoduodenectomy for acinar cell carcinoma. Acinar cell carcinoma is a relatively rare pancreatic neoplasm. Following the diagnosis of pancreatic carcinoma, subtotal stomach-preserving pancreaticoduodenectomy was performed. The pathological diagnosis was acinar cell carcinoma of the pancreas, disease stage IA, pT1, pN0, M0, without regional lymph node invasion. Twenty-two months after the surgery, cancer antigen 19-9 levels gradually increased, and computed tomography showed 2 solid tumors, approximately 1.1 and 2.1 cm in diameter, respectively, at the site of the remnant pancreas. Endoscopic ultrasound fine-needle aspiration revealed pancreatic ductal adenocarcinoma. The tumor cells were not immunoreactive for trypsin. Both tumors were diagnosed as PDAC of the remnant pancreas. The patient refused treatment with curative resection. Thus, as an alternative treatment, chemoradiotherapy was initiated. However, 28 months after surgery, the patient succumbed to the disease. Because this is an extremely rare case, further cases and studies are needed to understand its pathogenesis.

Information related to the author
© 2019 by the Medical Association of Nippon Medical School
Previous article